Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 511-515, March 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J. J.
Right arrow Articles by Rosen, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J. J.
Right arrow Articles by Rosen, J. M.

Comparative Biochemical Studies of Adriamycin and Daunomycin in Leukemic Cells1

Jaw J. Wang2, David S. Chervinsky and Jeffrey M. Rosen3

Department of Pediatrics [J. J. W., D. S. C.] and Experimental Therapeutics [J. M. R.], Roswell Park Memorial Institute, Buffalo, New York 14203

Adriamycin (AM) and daunomycin (DM) were compared as inhibitors of nucleic acid and protein biosynthesis in L1210 leukemic cells. In vivo, both antibiotics markedly inhibited, without significant difference, the incorporation of the labeled precursors into DNA and RNA. In vitro, at a concentration of 5 or 10 {varepsilon}g/ml, DM was significantly more effective than AM in inhibiting DNA and RNA synthesis in L1210 leukemic cells. Results of studies with leukemic cells isolated from the blood of patients are the same as those obtained with L1210 cells in vitro.

The reaction catalyzed in vitro by DNA polymerase, isolated from L1210 cells, was equally inhibited by AM and DM, although no effect on the enzyme was seen when the drugs were given in vivo. Studies with L1210 cells, resistant to AM or DM, suggest cross-resistance between the drugs.

1 This work was supported in part by United Health Fund Grant C1-7-RP-70, and by American Cancer Society Institutional Research Grant IN-54-K5.

2 To whom reprint requests should be addressed at the Department of Pediatrics, Roswell Park Memorial Institute, 666 Elm Street, Buffalo, N. Y. 14203.

3 Present address: Department of Obstetrics and Gynecology, Vanderbilt University, Nashville, Tenn.

Received 7/30/71. Accepted 12/ 3/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.